MedPath

VOSEVI 400 MG/100 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

VOSEVI 400 MG/100 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1171223001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Aug 12, 2017

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1171223001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (3)

SOFOSBUVIRActive
Quantity: 400 mg
Name: SOFOSBUVIR
VELPATASVIRActive
Quantity: 100 mg
Name: VELPATASVIR
VOXILAPREVIRActive
Quantity: 100 mg
Name: VOXILAPREVIR

ATC CLASSIFICATION (3)

J05A
J05AP
J05AP56

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.